Articles tagged with Gram Positive Bacteria
Researchers at the University of Houston discovered that T. phoenicis can enter dormancy to evade detection, highlighting the resilience of spacecraft-associated microbes and raising concerns about planetary protection. The findings may lead to better detection methods and more effective sterilization strategies in various industries.
Researchers mapped the frequencies used by Staphylococcus bacteria to communicate, identifying a signal from another species as potent against MRSA. This alternative technique weakens bacterial ability to coordinate attacks on hosts without killing them.
Researchers have discovered a synthetic compound called infuzide that effectively targets and kills antimicrobial resistant strains of Staphylococcus aureus and Enterococcus in laboratory and mouse tests. The findings suggest that infuzide works differently from other antimicrobials, which may help prevent resistance.
Moleculera Biosciences, a precision medicine company, is attracting investors with its technology developed by the University of Oklahoma. The company's diagnostic tests have helped properly diagnose over 16,000 patients and have shown remarkable recoveries in those affected by autoimmune disorders.
A Kobe University team developed a DNA base editing technology that enables precise control over microorganism genetic content without using template DNA from other organisms. They successfully applied this technique to industrially important Lactobacillus strains, creating safer probiotics for people with type 2 diabetes.
Recent studies have found that new antibiotics are prone to rapid development of resistance, even before they are widely used. This raises concerns about the effectiveness of these treatments in the long run. To address this issue, researchers call for a shift in antibiotic development prioritizing novel modes of action and responsible...
Research finds that Streptococcus mutans's collagen-binding protein may induce hematuria and IgA deposition in kidney disease, suggesting a potential pathogenic role. The study suggests a link between oral pathogens and renal lesions.
A new study has identified novel strains of microbes that have adapted to use limited resources in cities, including those found in Hong Kong's subways and skin. These microbes can metabolize manufactured products, posing health risks if they are pathogenic.
A study by Pusan National University researchers found a significant association between Cutibacterium acnes and lichen striatus hypopigmentation, suggesting the potential for targeted therapy to reduce LS duration and hypopigmentation. The research team identified other likely candidates in skin microbiota imbalance.
A team from the University of Basel identified 35 previously unknown bacterial pathogens and classified another 26 as difficult to identify. Many of these newly discovered species are associated with clinically relevant infections and can cause rare infections in humans.
Researchers have identified polyalthic acid, a compound in copaiba oil, with potent antibacterial activity against Gram-positive bacteria. The study's findings pave the way for developing alternative medications to combat antimicrobial resistance.
Researchers at NUS and Imperial College London have discovered a new way bacteria share genes, enabling rapid evolution. Lateral cotransduction enables SaPIs to transfer themselves intact with bacterial DNA, making them potent transducing agents.
Research reveals that asymptomatic throat carriage of Streptococcus pyogenes is the primary source of Group A Streptococcus (GAS) infections in high-risk communities. This discovery challenges previous understanding of GAS transmission and has significant implications for public health approaches, vaccine development, and future research.
Bacteria have found a way to survive stressful environments by producing microscopic syringes called Streptomyces phage tail-like particles (SLPs) that are located inside the cell. These SLPs interact with cellular systems involved in cell wall synthesis and protein translation, providing resistance against osmotic stress.
A team from the University of Tsukuba has discovered characteristics of proteins in bacteria that convey antibiotic resistance, providing insights into their function and role. These proteins, known as ARE-ABCFs, work in synergy with other resistance mechanisms to convey extremely high levels of antibiotic resistance.
Researchers have isolated two new bacterial species from patients with inflammatory bowel disease (IBD), which break down the protective mucus layer of the gut. The bacteria, Allobaculum mucilyticum and Allobaculum fili, are highly efficient at degrading intestinal mucus, leading to potent immune responses.
Researchers at Hokkaido University have developed a new class of antibacterial compounds targeting MraY, effective against MRSA and VRE. The findings provide a promising lead for the development of more effective antibiotics against multidrug-resistant bacteria.
A new class of light-activated hemithioindigo molecules developed by Rice University scientists kill specific Gram-positive bacteria and their biofilms. The molecules induce reactive oxygen species that chemically attack and destroy drug-resistant cells, offering a safer alternative to conventional antibiotics.
Researchers from NUS Medicine developed a probiotic that detects antibiotic-induced microbiome imbalance and regulates bile salt metabolism to prevent Clostridioides difficile infection. The probiotic significantly reduced CDI in laboratory models, demonstrating a 100% survival rate and improved clinical outcomes.
Researchers have designed a nano-copper coating with zinc that kills bacteria by rupturing their cell wall, reducing the incidence of bacterial infections on high-touch surfaces.
A recent study has found that ocean plastic may be a source of novel antibiotics, with researchers isolating five antibiotic-producing bacteria from plastic debris. The isolated bacteria showed promise against commonly used and resistant bacterial strains, providing hope for an alternative solution to the growing antibiotic crisis.
Researchers from the University of Tsukuba discovered a mechanism for the transfer of antibiotic resistance among Staphylococcus aureus bacteria through natural transformation. The study found that biofilm formation promotes horizontal gene transfer, which can lead to the spread of methicillin resistance.
SMART researchers identified a novel phage lysin, Abp013, with promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae. The study demonstrated Abp013's ability to effectively target complex bacterial environments and could advance treatment methods for multidrug-resistant Gram-negative pathogens.
A new study reveals that iboxamycin effectively fights both gram-negative and gram-positive drug-resistant bacteria in mouse models. The researchers discovered the molecular mechanism that allows this drug to overcome resistance, which is important for developing new antibiotics.
Researchers discovered that blocking bacterial H2S biogenesis strengthens antibiotics by inhibiting persister formation and biofilm growth, offering a novel alternative to traditional antibiotic discovery. The study suggests using small molecule potentiators to enhance the effect of major classes of clinically important antibiotics.
A new gene cluster in Staphylococcus epidermidis enables the bacteria to produce structures that allow them to attach to human cells and form a persistent infection. This discovery could lead to better treatments or vaccinations against methicillin-resistant S. aureus.
Researchers have identified compounds in Baltic amber that show activity against gram-positive, antibiotic-resistant bacteria. These compounds, including abietic acid and dehydroabietic acid, could lead to new medicines for treating infections caused by these resistant bacteria.
Scientists have discovered a natural inhibitor of topoisomerases II that can combat fluoroquinolone-resistant gram-negative bacteria. Nybomycin, a 'reverse antibiotic,' blocks the gyrase enzyme, rendering it effective against strains previously resistant to other antibiotics.
Researchers studied bacterial predation behavior in Myxococcus xanthus, revealing a mix of direct contact and protein-based killing methods to tackle different prey types. The findings provide insights into dynamic interactions in bacterial communities, paving the way for future antibacterial strategy development.
Researchers at Osaka City University demonstrated the mechanism behind FMT, showing how FMT can restore human intestinal flora by replacing damaged microflora with a healthy one. The study reveals the crucial role of bacteriophages and their host bacteria in the pathogenesis of rCDI and its recovery.
Researchers found that two families of gut bacteria interfere with radiotherapy in mice, reducing the effectiveness of treatment. The study identified a short-chain fatty acid called butyrate as the key compound responsible for this effect, which interferes with the activation of cytotoxic T cells and dendritic cells.
Researchers at the University of Queensland have discovered that synthetic cannabidiol can kill certain types of bacteria responsible for serious infections. The study's findings suggest that cannabidiol could lead to the development of new antibiotics, which would be a major breakthrough in combating antibiotic resistance.
Wistar scientists have discovered a new class of compounds that combine direct antibiotic killing with a rapid immune response to combat antimicrobial resistance. These dual-acting immuno-antibiotics target an essential bacterial pathway and stimulate the adaptive immune system, showing promise in treating pan drug-resistant infections.
Researchers analyzed fecal samples from healthy Japanese individuals and detected phage-derived antibacterial enzymes that control pathobionts. These enzymes were shown to regulate C. difficile infection in mice, providing a potential treatment for this disease.
Researchers found a link between gram-negative bacteria and cerebral cavernous malformations, which can cause hemorrhagic strokes, seizures, or headaches. The study showed that gut bacteria from CA patients produced more lipopolysaccharide molecules, driving CA formation in mice.
Researchers at the University of Basel have elucidated a mechanism in which certain bacteria, including MRSA, withstand acidic conditions. This is achieved through the synthesis and transportation of lipoteichoic acids, which provide stability to the bacterial cell wall.
Researchers developed AB569, a combination of acidified nitrite and disodium ethylenediaminetetraacetic acid, which killed Gram-negative and Gram-positive bacterial pathogens, including Pseudomonas aeruginosa. The agent was found to be nontoxic to human cells at bactericidal concentrations, suggesting a potential therapeutic agent for ...
Researchers at RMIT University have developed a new technology to destroy bacteria and bacterial biofilm without harming good cells, offering a potential solution to the deadly problem of antibiotic resistance. The technology uses precision-engineered liquid metals to physically rip bacteria to shreds and smash through the biofilm wher...
Researchers at Baylor College of Medicine discovered that amoebae build a barrier around their colonies to counteract bacterial attacks. The protein CadA enables the amoebae to recognize specific species and adapt to survive, forming clumps with Gram-negative bacteria and allowing for feeding on the edges.
University of Minnesota researchers have identified a novel circuit in the cell membrane that signals changes to bacterial surface adhesive proteins. This intramembrane signaling system appears to provide a 'fail-safe' mechanism to edit surface proteins and enable bacteria to adhere and colonize different body surfaces.
A team of researchers at POSTECH has developed a fluorescent probe called BacGo that can detect Gram-positive bacteria precisely and promptly. The probe is more sensitive than the traditional Gram staining method, which has several limitations, including slow detection and limited selectivity against Gram-positive bacteria.
Bacteria can create a wide range of derivatives from simple basic structures through mechanisms similar to pharmaceutical research. This diversification allows them to counteract unknown competitors and exhibit a wide range of biological activity.
Researchers found natural antibiofilm and antimicrobial peptides in bacteria, fungi, and yeast that can treat infections. The APD3 database reported 333 bacteriocin and peptide antibiotics with varying amino acid lengths and structures.
Scientists at Scripps Research have discovered the role of USP18 in the immune system. Deleting this protein enhances the body's ability to control infections with Gram-positive bacteria, while its normal induction impairs antibacterial responses. Researchers hope to develop therapies targeting USP18 to treat bacterial infections.
Researchers at Lehigh University have designed a small-molecule compound to decorate the surface of Gram-negative bacteria and trigger an immunological response. The compound targets pathogenic bacteria in two distinct ways, generating a promising lead for immunotherapeutic agents against deadly, antibiotic-resistant bacteria.
Researchers at North Carolina State University have synthesized a new compound inspired by a natural product that is effective against drug-resistant bacteria like MRSA. The molecule, JJM-35, has been shown to be up to 50 times more effective than the original natural product against several bacterial strains.
A global study found that 34% of bacterial infections in patients with cirrhosis across the world are multi-drug resistant, with significant regional differences. The risk of developing a multi-drug-resistant infection was higher in Asia, particularly India, and among patients who had recently received antibiotics.
Researchers have discovered a key member of the SEDS protein family, RodA, which builds bacterial walls. Altering its structure can disrupt this function, making it an attractive target for new antibiotics.
Researchers from North Carolina State University have identified potential compounds that could inhibit the virulence of Listeria by targeting an enzyme involved in bacterial cell surface modifications. Inhibiting this enzyme renders Listeria less virulent, making it a promising approach for combating severe food poisoning and listerio...
A novel PET tracer, 6"-18F-fluoromaltotriose, has been developed to identify most bacterial infections. The agent is a derivative of maltose and targets the maltodextrin transporter in bacteria, allowing for non-invasive detection and monitoring of antibiotic therapy.
Bacterial membrane vesicles are nanoscale spheres formed by bacteria, potentially used in cancer treatment and nanotechnology. Researchers visualized their formation using live cell imaging and electron cryotomography, revealing that endolysin enzymes play a crucial role in their production.
Researchers have found that bacterial cell wall constituents can cause abnormal clotting, leading to inflammation in Type 2 diabetes. A new treatment option involves using LPS-binding protein (LBP) to reverse this process, offering a new approach to treating the disease.
Researchers at Vanderbilt University Medical Center have developed a new light-based therapy to kill antibiotic-resistant bacteria, such as MRSA. The therapy uses a small molecule to activate an enzyme that produces reactive oxygen species, killing the bacteria when exposed to specific wavelengths of light.
Wonpil Im's open-source biomolecular modeling tool CHARMM-GUI simulates bacterial membrane channels and transport of antibiotic molecules, supporting the fight against antibiotic resistance. Gram-negative bacteria's outer membrane poses a significant challenge to antibiotic penetration.
A study found that Lactobacillus parafarraginis isolated from commercial yogurt inhibited the growth of several multidrug-resistant bacterial pathogens. The bacteriocin-like peptide responsible for this inhibition is heat stable and may hold promise as a therapeutic agent.
Scientists have developed a new broad-spectrum antibiotic that can target gram-negative bacteria, which are increasingly resistant to most available antibiotics. The breakthrough was achieved by modifying a drug that kills only gram-positive bacteria and discovered key traits required for access to the bacterial cell.
Researchers used physics equations to track bacterial battles over sustenance and turf, gaining insights for new targeted therapies against infections. Cholera bacteria wield harpoon-like appendages covered in poison, with a correlation found between weaponry and cooperative social behavior.
Researchers from Lomonosov Moscow State University have isolated a unique strain of lactic acid bacteria, Lactococcus lactis subsp. lactis 194, from Buryat milk that possesses a wide range of antimicrobial action against Gram-positive and Gram-negative bacteria. The strain also shows antifungal properties, making it a promising candida...
Marcos Pires, a Lehigh University assistant professor of chemistry, has pioneered an immunotherapy approach to combat bacterial infections. His method involves molecularly tagging pathogenic bacteria to attract antibodies, offering a novel strategy to defeat Gram-positive and Gram-negative bacteria.
Researchers at University of Illinois developed spiral polypeptides that target bacteria's outer membrane, perforating it until the cell falls apart. The antimicrobial agents are designed to interact with bacterial membranes while minimizing interaction with human cells.